s6y
Company name or ticker
Search
BridgeBio Oncology Therapeutics, Inc.
POS AM
Post-effective amendment to a registration statement that is not immediately effective upon filing
Filed
Thursday, April 30, 2026
Accession number
0001193125-26-197901
Documents
POS AM
POS AM
EX-23.1
EX-23.1
XBRL TAXONOMY EXTENSION SCHEMA
EX-101.SCH
On sec.gov
Filing index
All files
Complete submission text
SGML header